Sharps Technology- Warrants (13/04/2027) (STSSW) has a profit margin of -15914.89%, below the Healthcare sector average of 14.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for STSSW is -15914.89% as of June 2026. That compares with -324.78% in the prior-year period — down 4800.3% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Sharps Technology- Warrants (13/04/2027)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, STSSW's profit margin moved from -324.78% to -15914.89% — a 4800.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sharps Technology- Warrants (13/04/2027)'s valuation or profitability profile.
Against Healthcare companies, STSSW currently prints -15914.89% for profit margin, while the sector average sits near 14.34%. That is roughly 111045.5% below the sector mean. Large gaps often invite a closer look at Sharps Technology- Warrants (13/04/2027)'s growth, margins, and balance sheet.
Profit Margin shows how effectively Sharps Technology- Warrants (13/04/2027) converts resources into returns. At -15914.89%, STSSW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -324.78% in the prior-year period — down 4800.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting STSSW's profit margin (-15914.89%), review year-over-year change from -324.78%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.